1. Home
  2. TCRT

TCRT

Alaunos Therapeutics Inc.

Logo Alaunos Therapeutics Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-19-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Alaunos Therapeutics Inc is a clinical-stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. It strikes cancer at its core by engineering cell therapies that target Neoantigens arising from genomic mutations.

Founded: 1998 Country:
United States
United States
Employees: N/A City: HOUSTON
Market Cap: 25.8M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 121.2K
Analyst Decision: Hold Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.20 EPS Growth: N/A
52 Week Low/High: $0.60 - $10.50 Next Earning Date: 05-08-2024
Revenue: $5,000 Revenue Growth: -99.83%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: